2nd Quarter - Report
CAPITOL CONSULTING GROUP, LLC for TERUMO BCT (FORMERLY CARIDIANBCT BIOTECHNOLOGIES LLC)
Income
$10,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2012 | $10,000 | Replaced |
| 2nd Quarter - Report (this page) | Jul 19, 2012 | $10,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Blood pathogen reduction technology development
Foreign entity interest: Owner
| Lobbyist | Covered position, as disclosed |
|---|---|
| LYNN HENSELMAN | — |
| PATRICK HIU | — |
| GILLIAN JAEGER | — |
Medical/Disease Research/Clinical Labs MED
Blood pathogen reduction technology development
Foreign entity interest: Owner
| Lobbyist | Covered position, as disclosed |
|---|---|
| LYNN HENSELMAN | — |
| PATRICK HIU | — |
| GILLIAN JAEGER | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TERUMO CORPORATION | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.